STUDY PROTOCOL
Accepted on 31 Jan 2025
Nab-Paclitaxel Combined with Cadonilimab (AK104) as Second-Line Treatment for Advanced Gastric Cancer: Protocol for a Phase II Prospective, Multicenter, Single-Arm Clinical Trial
doi 10.3389/fimmu.2025.1519545
1,915
Total downloads
13k
Total views and downloads
Select the journal/section where you want your idea to be submitted:
STUDY PROTOCOL
Accepted on 31 Jan 2025
SYSTEMATIC REVIEW
Published on 27 Jan 2025
CASE REPORT
Published on 08 Jan 2025
BRIEF RESEARCH REPORT
Published on 17 Dec 2024
ORIGINAL RESEARCH
Published on 07 Nov 2024
ORIGINAL RESEARCH
Published on 24 Oct 2024
ORIGINAL RESEARCH
Published on 27 Sep 2024
Frontiers in Oncology
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Select the journal/section where you want your idea to be submitted: